PBL Assay Science broadens offerings with authentic human cell-expressed cytokines and growth factors in licensing agreement with HumanZyme, Inc. - CW Richmond WUPV |

PBL Assay Science broadens offerings with authentic human cell-expressed cytokines and growth factors in licensing agreement with HumanZyme, Inc.

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE PBL Assay Science

PISCATAWAY, N.J., Feb. 19, 2014 /PRNewswire/ -- PBL Assay Science announces a licensing agreement with HumanZyme, Inc. (Chicago, USA) to expand reagent offerings.  The agreement allows PBL to provide ~50 authentic human cell-expressed (HCE) cytokines and growth factors directly to scientists worldwide.

HumanZyme, Inc. is a global leader in providing highly authentic recombinant proteins from human cells under the HumanKine® brand and a preferred outsourcing supplier of human protein production.   These human cell-expressed proteins mimic native human proteins more closely than proteins from non-human expression systems, such as E. coli, in terms of glycosylation, assembly, location, and structure. 

PBL Assay Science is a major provider of products, assay services, and information related to interferons, cytokines, antibodies, ELISAs, and assay science. The company employs state-of-the-art technology and years of know-how in conducting assay services and manufacturing world-class products for scientists around the globe.  Learn more at pblassaysci.com.

"HumanZyme's leadership and innovations in authentic human proteins provide a perfect complement to our unique cytokine and interferon reagents, ELISA, and assay service offerings," said Robert Pestka, CEO, PBL Assay Science. "Introducing these proteins to our product line enhances our ability to help scientists approach their experiments using more biologically relevant research tools."

"For over twenty years, PBL has grown not only in number of products offered but in knowledge around interferons, cytokines and assay science," said Sean Doctor, Executive Vice President and GM, HumanZyme, Inc.  "Combining our human cell-expressed reagents with PBL's expertise expands both companies' capability to address researchers' most difficult problems."

The agreement between PBL Assay Science and HumanZyme, Inc. begins this month.  Human cell-expressed (HCE) proteins in the agreement include members of the human TGF beta, Fibroblast Growth Factor (FGF), Hematopoietin and Interleukin, and Tyrosine Kinase Receptor Signaling families, and TNF-alpha.  To learn more, contact Stephen Parent, PBL Assay Science's Director of Business Development, at sparent@pblbio.com or 1-732-777-9123 ext. 117.              

Contact: Stephen A. Parent
(732) 777-9123 x 117

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WUPV. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service